Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Apr 2, 2015
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Sale
Common Stock
2015-04-01$9.90/sh−7,262$71,894→ 344,036 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.